Your browser doesn't support javascript.
loading
Cisplatin or Doxorubicin Reduces Cell Viability via the PTPIVA3-JAK2-STAT3 Cascade in Hepatocellular Carcinoma.
Li, Chao-Jen; Tsai, Hung-Wen; Chen, Yi-Li; Wang, Chun-I; Lin, Yang-Hsiang; Chu, Pei-Ming; Chi, Hsiang-Cheng; Huang, Yi-Ching; Chen, Cheng-Yi.
Affiliation
  • Li CJ; Department of General & Gastroenterological Surgery, An Nan Hospital, China Medical University, Tainan, Taiwan.
  • Tsai HW; Department of Pathology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Chen YL; Department of Cell Biology and Anatomy, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Wang CI; Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan.
  • Lin YH; Liver Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Chu PM; Department of Anatomy, School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
  • Chi HC; Department of Medical Education, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • Huang YC; Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.
  • Chen CY; Chinese Medicine Research Center, China Medical University, Taichung, Taiwan.
J Hepatocell Carcinoma ; 10: 123-138, 2023.
Article in En | MEDLINE | ID: mdl-36741246

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Screening_studies Language: En Journal: J Hepatocell Carcinoma Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Screening_studies Language: En Journal: J Hepatocell Carcinoma Year: 2023 Document type: Article Affiliation country: Country of publication: